Lisdexamfetamine 30 MG capsule 100S
Ended Awarded
- Contract number
- SPE2DB25FN2UZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,931
Award facts
- Contract value 100% obligated
- $1,931.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 27, 2025, for the supply of Lisdexamfetamine 30 mg capsules (100-count units) with a ceiling value of $1,931.32. This is a firm fixed price delivery order without set-aside designation, demonstrating competitive award of this pharmaceutical product. The order is scheduled for completion by June 30, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive $999.99 billion global pharmaceutical support vehicle running through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical supplier to the Department of Defense and other federal healthcare systems through its extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies. The company's federal contract awards with the Defense Logistics Agency reflect its capacity to fulfill diverse pharmaceutical procurement requirements across multiple therapeutic domains, supporting military and veteran healthcare operations globally. This delivery order for Lisdexamfetamine—a central nervous system stimulant used in the treatment of attention deficit hyperactivity disorder—represents a routine fulfillment of medical supply needs within the broader strategic partnership between AmerisourceBergen and the Defense Logistics Agency.
Quick answers
Who was awarded contract SPE2DB25FN2UZ?
SPE2DB25FN2UZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 27, 2025.
How much is contract SPE2DB25FN2UZ worth?
The government has obligated $1,931 on SPE2DB25FN2UZ.
Is contract SPE2DB25FN2UZ an order under another contract?
Yes. SPE2DB25FN2UZ is a delivery order under SPE2DB22D1200, an indefinite delivery contract.
Was contract SPE2DB25FN2UZ competed?
The extent of competition for SPE2DB25FN2UZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award